Immunohistochemistry
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human Transient Receptor Potential Channel 6 (NT) (TRPC6) - 0.1 mg | Anmelden | Anti-Human Transient Receptor Potential Channel 6 (NT) (TRPC6) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRIM5α (Intermediate Domain 1) - 0.1 mg | Anmelden | Anti-Human TRIM5α (Intermediate Domain 1) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRIM5α (CT) - 0.1 mg | Anmelden | Anti-Human TRIM5α (CT) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRIM5α (Intermediate Domain 2) - 0.1 mg | Anmelden | Anti-Human TRIM5α (Intermediate Domain 2) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRIM5γ - 0.1 mg | Anmelden | Anti-Human TRIM5γ - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRIM5δ - 0.1 mg | Anmelden | Anti-Human TRIM5δ - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Tuberous Sclerosis Complex 1 (Intermediate Domain) (T - 0.1 mg | Anmelden | Anti-Human Tuberous Sclerosis Complex 1 (Intermediate Domain) (T - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Tuberous Sclerosis Complex 2 (NT) (TSC2) - 0.1 mg | Anmelden | Anti-Human Tuberous Sclerosis Complex 2 (NT) (TSC2) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TNF-Related Weak Inducer of Apoptosis (TWEAK) - 0.1 mg | Anmelden | Anti-Human TNF-Related Weak Inducer of Apoptosis (TWEAK) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse Vγ 3 (TCR) - Biotin - 500 µg | Anmelden | Anti-Mouse Vγ 3 (TCR) - Biotin - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse Vγ 3 (TCR) - Purified - 100 µg | Anmelden | Anti-Mouse Vγ 3 (TCR) - Purified - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Tau - Purified - 0.25 mg | Anmelden | Anti-Tau - Purified - 0.25 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Tau-Biotin - 0.25 mg | Anmelden | Anti-Tau-Biotin - 0.25 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TIM-1 (NT) - 20 µg | Anmelden | Anti-Human TIM-1 (NT) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TNF-Related Weak Inducer of Apoptosis (TWEAK) - 20 µg | Anmelden | Anti-Human TNF-Related Weak Inducer of Apoptosis (TWEAK) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TACI - 20 µg | Anmelden | Anti-Human TACI - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRIM5α (Intermediate Domain 1) - 20 µg | Anmelden | Anti-Human TRIM5α (Intermediate Domain 1) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TNFRSF14 (CT) - 20 µg | Anmelden | Anti-Human TNFRSF14 (CT) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TNFRSF14 (NT) - 20 µg | Anmelden | Anti-Human TNFRSF14 (NT) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Target of Rapamycin (TOR) - 20 µg | Anmelden | Anti-Human Target of Rapamycin (TOR) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Tail-Interacting Protein 47 (NT) (TIP47) - 20 µg | Anmelden | Anti-Human Tail-Interacting Protein 47 (NT) (TIP47) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Tuberous Sclerosis Complex 1 (Intermediate Domain) (T - 20 µg | Anmelden | Anti-Human Tuberous Sclerosis Complex 1 (Intermediate Domain) (T - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Transient Receptor Potential Channel 6 (NT) (TRPC6) - 20 µg | Anmelden | Anti-Human Transient Receptor Potential Channel 6 (NT) (TRPC6) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Transient Receptor Potential Channel 6 (CT) (TRPC6) - 20 µg | Anmelden | Anti-Human Transient Receptor Potential Channel 6 (CT) (TRPC6) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Transient Receptor Potential Channel 3 (NT) (TRPC3) - 20 µg | Anmelden | Anti-Human Transient Receptor Potential Channel 3 (NT) (TRPC3) - 20 µg | ||||||||||||||||
|
||||||||||||||||||


